Polyoma virus-induced osteosarcomas in inbred strains of mice: Host determinants of metastasis

PLoS Pathogens

Volumn 6, Issue 1, 2010, Pages

  Velupillai, Palanivel ^a   Sung, Chang Kyoo ^a   Tian, Yu ^a   Dahl, Jean ^a   Carroll, John ^a   Bronson, Roderick ^a   Benjamin, Thomas ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; OSTEOPONTIN; PROTEIN P53; TRANSCRIPTION FACTOR NFAT; SMALL INTERFERING RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; POLYOMA VIRUS; ANIMAL; BIOSYNTHESIS; BONE TUMOR; CELL MOTION; DISEASE MODEL; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; POLYOMAVIRUS INFECTION; VIROLOGY;

MUS; POLYOMAVIRUS;

ANIMALS; BONE NEOPLASMS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; IMMUNOBLOTTING; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; NEOPLASM INVASIVENESS; NFATC TRANSCRIPTION FACTORS; OSTEOPONTIN; OSTEOSARCOMA; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77649230351     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000733     Document Type: Article

References (43)

1. Molloy T, van 't Veer LJ (2008) Recent advances in metastasis research. Curr Opin Genet Dev 18: 35-41.
2. Cardiff RD, Munn RJ, Galvez JJ (2007) Chapter 24. The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology. In The Mouse in Biomedical Research, 2nd Edition JJ Fox, MT Davisson, FW Quimby, AW Barthold, CE Newcomer, AL Smith, editors Academic Press: 581-622.
3. Bilger A, Shoemaker AR, Gould KA, Dove WF (1996) Manipulation of the mouse germline in the study of Min-induced neoplasia. Semin Cancer Biol 7: 249-260.
4. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639.
5. Balmain A, Nagase H (1998) Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet 14: 139-144.
6. Benjamin TL (2007) Chapter 5. Polyoma Viruses. In The Mouse in Biomedical Research, 2nd Edition JJ Fox, MT Davisson, FW Quimby, AW Barthold, CE Newcomer, AL Smith, editors Academic Press: 105-139.
7. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, et al. (2003) Gangliosides are receptors for murine polyoma virus and SV40. Embo J 22: 4346-4355.
8. Carroll J, Dey D, Kreisman L, Velupillai P, Dahl J, et al. (2007) Receptorbinding and oncogenic properties of polyoma viruses isolated from feral mice. PLoS Pathog 3: e179. doi:10.1371/journal.ppat.0030179.
9. Bauer PH, Bronson RT, Fung SC, Freund R, Stehle T, et al. (1995) Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J Virol 69: 7925-7931.
10. Bronson R, Dawe C, Carroll J, Benjamin T (1997) Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc Natl Acad Sci U S A 94: 7954-7958.
11. Freund R, Bronson RT, Benjamin TL (1992) Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene 7: 1979-1987.
12. Freund R, Calderone A, Dawe CJ, Benjamin TL (1991) Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J Virol 65: 335-341.
13. Freund R, Dawe CJ, Carroll JP, Benjamin TL (1992) Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol 141: 1409-1425.
14. Dawe CJ, Freund R, Mandel G, Ballmer-Hofer K, Talmage DA, et al. (1987) Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol 127: 243-261.
15. Schaffhausen BS, Roberts TM (2009) Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer. Virology 384: 304-316.
16. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
17. Jessen KA, Liu SY, Tepper CG, Karrim J, McGoldrick ET, et al. (2004) Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res 6: R157-169.
18. Velupillai P, Yoshizawa I, Dey DC, Nahill SR, Carroll JP, et al. (1999) Wildderived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors. J Virol 73: 10079-10085.
19. Uribe-Botero G, Russell WO, Sutow WW, Martin RG (1977) Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54. Am J Clin Pathol 67: 427-435.
20. Lukacher AE, Ma Y, Carroll JP, Abromson-Leeman SR, Laning JC, et al. (1995) Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 181: 1683-1692.
21. Whalen KA, Weber GF, Benjamin TL, Schaffhausen BS (2008) Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J Virol 82: 4946-4954.
22. Albini A (1998) Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 4: 230-241.
23. Loukopoulos P, O'Brien T, Ghoddusi M, Mungall BA, Robinson WF (2004) Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases. Res Vet Sci 77: 131-141.
24. Rao A, Luo C, Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747.
25. Alfonso-Jaume MA, Mahimkar R, Lovett DH (2004) Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. Biochem J 380: 735-747.
26. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, et al. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540-544.
27. Pan S, Koyano-Nakagawa N, Tsuruta L, Amasaki Y, Yokota T, et al. (1997) Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc. Biochem Biophys Res Commun 240: 314-323.
28. Sherman MA, Powell DR, Weiss DL, Brown MA (1999) NF-ATc isoforms are differentially expressed and regulated in murine T and mast cells. J Immunol 162: 2820-2828.
29. Luo C, Burgeon E, Carew JA, McCaffrey PG, Badalian TM, et al. (1996) Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol 16: 3955-3966.
30. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC (1998) Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392: 42-48.
31. Ries C, Egea V, Karow M, Kolb H, Jochum M, et al. (2007) MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055-4063.
32. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839.
33. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7.
34. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, et al. (2004) Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119: 861-872.
35. Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, et al. (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119: 847-860.
36. Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, et al. (2008) Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 22: 1662-1676.
37. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, et al. (2008) Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A 105: 11851-11856.
38. Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, et al. (2001) Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 92: 2181-2189.
39. Dey DC, Bronson RP, Dahl J, Carroll JP, Benjamin TL (2000) Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds. Cell Growth Differ 11: 231-237.
40. Dahl J, You J, Benjamin TL (2005) Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol 79: 13007-13017.
41. Larose A, Dyson N, Sullivan M, Harlow E, Bastin M (1991) Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J Virol 65: 2308-2313.
42. Giannelli G, Astigiano S, Antonaci S, Morini M, Barbieri O, et al. (2002) Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis 19: 217-223.
43. Wang DR, Sato M, Li LN, Miura M, Kojima N, et al. (2003) Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells. Cell Struct Funct 28: 505-513.